vaccine immune response
Scope
Date
~
-
Bio & Pharma
GC Biopharma wins approval for quadrivalent flu vaccine in Egypt
South Korea's GC Biopharma Corp. announced on Wednesday that its quadrivalent influenza vaccine "GC Flu Quadrivalent" has received approval from Egy...
Jul 19, 2023 (Gmt+09:00)
-
Logistics
CJ Logistics revamps itself into tech-based company
South Korea’s CJ Logistics on Monday said it has revamped its internal organization that it had maintained since its foundation in 1930. ...
Jul 11, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience, Thai’s GPO to jointly boost vaccine infrastructure
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Wednesday that it has signed a memorandum of understanding (MO...
Jul 05, 2023 (Gmt+09:00)
-
Electronics
Samsung Display sues BOE over iPhone 12 panel patents
Samsung Display Co. has stepped up its fight against BOE Technology over display panels, taking its first legal action against the Chinese rival ove...
Jun 30, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's SK Bioscience to resume domestic flu vaccine output
South Korea's SK Bioscience Co. will resume making domestic flu vaccines by year's end, two years after it stopped production to supply a vaccine fo...
Jun 14, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience’s COVID-19 vaccine gets approval in UK
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Monday that its domestic COVID-19 vaccine, SKYCovione, has rec...
May 30, 2023 (Gmt+09:00)
-
North Korea
S.Korea warns of stern response in case of N.Korea satellite launch
The launch of North Korea's first military reconnaissance satellite has entered a “countdown”. North Korea notified the Japanese governm...
May 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine
South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...
May 23, 2023 (Gmt+09:00)
-
Bio & Pharma
HLB submits new drug application to FDA for Rivoceranib liver cancer drug
HLB Co. announced on May 17 that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for the approval of Rivo...
May 19, 2023 (Gmt+09:00)
-
Automobiles
Kia offers up to $7,500 in incentives in US for leasing EV6
South Korea's Kia Corp. is offering discounts of up to $7,500 in the US for leasing its electric compact crossover SUV line EV6 to boost its price c...
May 17, 2023 (Gmt+09:00)
-
Electronics
Samsung Electronics to open flagship store in Seoul's Gangnam district
Samsung Electronics Co. in late June will open its new flagship store Samsung Gangnam near Gangnam Station, a posh area of Seoul.Sources from the in...
May 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Lemonex signs MOU with WHO mRNA vaccines tech hub
South Korea's gene therapeutics developer Lemonex announced on Tuesday that it has signed a memorandum of understanding (MOU) with the World Health ...
May 09, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to produce MSD’s new Ebola vaccine candidate
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, announced on Monday that it has signed a contract with MSD, a global pharma...
May 08, 2023 (Gmt+09:00)
-
Hydrogen economy
HMM, Lotte Fine Chemical to partner for ammonia sea transport
South Korea's HMM Co. and Lotte Fine Chemical Co. have formed a partnership to transport and supply next-generation environmentally friendly fuel, a...
Apr 24, 2023 (Gmt+09:00)
-
Batteries
LG Chem, China’s Huayou Cobalt to build $923 million precursor plant
South Korea’s top chemicals company LG Chem Ltd. and its Chinese partner Zhejiang Huayou Cobalt Co. will launch a 1.2 trillion won ($923 milli...
Apr 14, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins $44 mn flu vaccine order from WHO agency
South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a d...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's licensed flu vaccine gets approval in Taiwan
South Korea's pharmaceutical firm GC Biopharma Corp. announced on Monday that its quadrivalent flu vaccine has received marketing approval from the ...
Mar 13, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma to develop mRNA flu vaccine with Canadian pharma
South Korea's GC Biopharma Corp. announced on Thursday that it will start developing a flu vaccine based on messenger ribonucleic acid (mRNA).The dr...
Mar 09, 2023 (Gmt+09:00)
-
ESG
Kumho Petrochem wins BB rating from MSCI's ESG ratings
Kumho Petrochemical Co. announced on Wednesday that it had received a "BB rating" in the environmental, social and governance (ESG) evaluation by Mo...
Mar 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Phase 3 clinical plan for SK Bioscience's booster shot approved in Colombia
SK Bioscience Co., a leading South Korean vaccine and biotech company, announced on Monday that its phase 3 clinical trial plan for a heterogeneous ...
Mar 07, 2023 (Gmt+09:00)
-
Sovereign wealth funds
S.Korea's KIC to strengthen responsible investments
Korea Investment Corporation (KIC) plans to actively voice its opinions on portfolio companies' management over the next two years to tighten its re...
Mar 06, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's EuBiologics to receive support from Gates Foundation
South Korea's biopharmaceutical company EuBiologics Co. announced on Wednesday that its meningococcal pentavalent conjugate vaccine EuMCV5 under dev...
Feb 23, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Motor begins Genesis GV70 EV production in US
Hyundai Motor Co. has commenced production of the Genesis GV70 electric vehicle in the United States. This marks the first locally produced vehicle ...
Feb 23, 2023 (Gmt+09:00)
-
Fintech
Samsung Electronics, Naver partner to create simple payment service
Samsung Electronics Co. and South Korea's Naver Financial have formed a simple payment service alliance in which users of Samsung Pay can make simpl...
Feb 21, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma gets WHO pre-qualification approval for chickenpox vaccine
South Korea's GC Biopharma Corp. is set to regain the No. 1 spot in global production of chickenpox vaccines after earning qualification to enter th...
Feb 21, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma, Sanofi to jointly market Plavix
GC Biopharma Co. (formerly Green Cross Corp.) said on Monday it has entered into a joint sales partnership with Sanofi-Aventis Korea, the South Kore...
Feb 13, 2023 (Gmt+09:00)
-
ESG
Responsible mineral sourcing key to Korean battery materials makers
South Korea’s battery materials makers are stepping up their efforts to conform to environmental, social and governance (ESG) standards throug...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanall Biopharma invests in Interon Labs for brain disease treatments
South Korean pharmaceuticals firm Hanall Biopharma Co. is investing in Interon Laboratories, a US biotech firm that finds and develops treatments fo...
Feb 13, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Ochang facility gets WHO PQ certification
GC Biopharma Co.'s production facility in Ochang (North Chungcheong Province) secured a pre-qualification (PQ) certification from the World Health O...
Feb 10, 2023 (Gmt+09:00)
-
Retail
CJ Olive Young faces discipline for abuse of power with suppliers
CJ Olive Young Co., South Korea’s top beauty store chain, will face punishment by the country’s antitrust regulator for abuse of power o...
Feb 08, 2023 (Gmt+09:00)